Jove
Visualize
联系我们

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Hazard Rate01:11

Hazard Rate

108
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
108
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

365
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
365
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

138
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
138
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

100
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
100

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study.

Gut·2026
Same author

Single-Cell Transcriptomics in Inherited Retinal Dystrophies: Current Findings and Emerging Perspectives.

Genes·2025
Same author

Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland.

Alimentary pharmacology & therapeutics·2025
Same author

Differential behaviour of a risk score for emergency hospital admission by demographics in Scotland-A retrospective study.

PLOS digital health·2024
Same author

Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison.

Journal of Crohn's & colitis·2024
Same author

Publisher Correction: Development and assessment of a machine learning tool for predicting emergency admission in Scotland.

NPJ digital medicine·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 3, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

统计和机器学习竞争风险方法的审查.

Karla Monterrubio-Gómez1, Nathan Constantine-Cooke1,2, Catalina A Vallejos1,3

  • 1MRC Human Genetics Unit, University of Edinburgh, Edinburgh, UK.

Biometrical journal. Biometrische Zeitschrift
|February 13, 2024
PubMed
概括

本研究提供了现代竞争性风险 (CR) 生存分析方法,统计和机器学习技术的指南. 它旨在通过提供清晰的解释和软件示例,在实践中增加先进CR生存模型的使用.

关键词:
竞争的风险竞争的风险.风险预测风险预测生存分析,生存分析.时间到事件数据.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

268

相关实验视频

Last Updated: Jul 3, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

268

科学领域:

  • 生物统计学 生物统计学
  • 机器学习 机器学习
  • 生存分析的分析.

背景情况:

  • 竞争风险 (CR) 生存数据建模在统计和机器学习领域都有进展.
  • 最先进的方法提供了更好的预测性能,高维数据处理和缺失值归算.
  • 这些现代CR生存方法在应用研究中的广泛采用仍然有限.

研究的目的:

  • 促进在应用研究中采用先进的竞争性风险生存方法.
  • 为CR生存技术提供统一的汇编,并提供一致的标记和解释.
  • 要突出可用的软件工具,并使用可重复的R vignettes来展示它们的应用.

主要方法:

  • 编译和综合现有的统计和机器学习方法,用于竞争风险生存分析.
  • 为各种CR生存方法开发统一的标记和解释框架.
  • 使用 R 片段来展示软件实现和可重现性的说明性示例.

主要成果:

  • 介绍了现代竞争性风险生存方法的全面概述.
  • 这篇文章提供了关于软件实现和可重复性分析的实际指导.
  • 讨论了基准研究的关键考虑因素,包括性能指标和可重复性.

结论:

  • 这项工作旨在弥合先进的竞争风险生存方法及其实际应用之间的差距.
  • 通过提供统一的摘要和实践演示,该研究鼓励更广泛地使用复杂的CR生存模型.
  • 强调绩效指标和可重复性对于在竞争风险分析中进行可靠的基准测试至关重要.